Gezondheid of mRNA, Recht & Vrijheid of Globalisme & Oorlog, Milieu of Klimaathysterie: Another Study Confirms Myocarditis Post Jab

dinsdag 6 december 2022

Another Study Confirms Myocarditis Post Jab

Analysis by Dr. Joseph Mercola Fact Checked December 05, 2022

STORY AT-A-GLANCE

· A study estimated the incidence of myocarditis after COVID-19 shots and compared it with expected rates in British Columbia; a significantly increased risk of myocarditis was found following COVID-19 jabs

· While seven myocarditis cases would be expected within seven days, the study found 99 cases among those who’d received the shots

· Within 21 days post-vaccination, 141 cases of myocarditis occurred. The expected rate was 20

· This worked out to a myocarditis rate of 1.37 per 100,000 COVID-19 doses, compared with an expected rate of 0.39 per 100,000 people who did not get the shots

· Rates of myocarditis after COVID-19 shots were highest among males, those aged 18 to 29 years, people who received a Moderna COVID-19 shot and people who received two doses

· The rate of myocarditis among males aged 18 to 29 who received Moderna’s COVID-19 shot was 22.9 per 100,000

Yet another study has revealed people who receive a COVID-19 shot are at an increased risk of myocarditis, or inflammation of the heart muscle.¹ With symptoms similar to a heart attack, including chest pain, shortness of breath, abnormal heartbeat and fatigue,² myocarditis isn’t something that young, healthy adults typically experience.

But soon after mRNA shots for SARS-CoV-2 became widespread, reports of myocarditis, including sudden death, began to emerge.³ In Canada, more than 32 million people had received COVID-19 shots as of September 2022.⁴

“Prelicensure study data did not suggest any risk of postvaccination myocarditis,” researchers with the British Columbia Centre for Disease Control wrote in the Canadian Medical Association Journal (CMAJ). However:⁵

“[P]ostmarketing studies have suggested an association between mRNA SARS-CoV-2 vaccines (BNT162b2 [Pfizer-BioNTech] and mRNA-1273 [Moderna]) and myocarditis, among other adverse events after immunization, which has raised concern regarding the safety of mRNA vaccines, specifically among younger populations.”

This prompted the featured study, which estimated the incidence of myocarditis after COVID-19 shots and compared it with expected rates in British Columbia. A significant increased risk of myocarditis was found following COVID-19 shots.

Getting a COVID-19 Shot Increases Risk of Myocarditis

The study used data from the BC COVID-19 Cohort study, which included more than 10.2 million doses of mRNA COVID-19 shots given to people 12 and over. Cases of myocarditis that occurred seven to 21 days after the shots and required hospitalization were examined. While seven myocarditis cases would be expected within seven days, the study found 99 cases among those who’d received the shots.

Within 21 days post-vaccination, 141 cases of myocarditis occurred. The expected rate was 20. This worked out to a myocarditis rate of 1.37 per 100,000 COVID-19 doses, compared with an expected rate of 0.39 per 100,000 people who did not get the shots.⁶ Rates of myocarditis after COVID-19 shots were highest among:⁷

· Males

· Those aged 18 to 29 years

· People who received a Moderna COVID-19 shot

· People who received two doses

The rate of myocarditis among males aged 18 to 29 who received Moderna’s COVID-19 shot was 22.9 per 100,000.⁸ The researchers concluded:⁹

“In this study, we found higher observed rates of myocarditis after receipt of mRNA vaccines than expected … We observed a higher rate of myocarditis among males aged 18-29 years after receipt of the second dose of mRNA-1273 (Moderna) vaccine compared with those who received BNT162b2 (Pfizer-BioNTech) …

Comparisons of observed with expected rates also confirmed these findings, with the highest observed-to-expected ratios among males 18–29 years of age after the second dose of the mRNA-1273 vaccine.”

Myocarditis Link to COVID-19 Jabs Confirmed Again and Again

Many case reports exist of myocarditis following COVID-19 jabs, but they’re still recommended as safe and effective in the U.S. The Journal of Cardiology Cases described the case of a 23-year-old man who was otherwise healthy, who experienced chest pain for three days after receiving the second dose of Pfizer’s COVID-19 shot.

Myocarditis was confirmed via MRI and other medical tests, and he was diagnosed with “acute myocarditis after COVID-19 vaccination.”¹⁰ In another example, researchers reviewed nine case series and 15 case reports involving 74 patients of myocarditis after mRNA COVID-19 shots. Again, most of the patients (94.6%) were male and young, with a median age of 17.6 years.¹¹

In a September-October 2021 case report with literature review, it was concluded that “the outcomes of this case scenario confirm myocarditis as a probable complication of COVID-19 vaccines.”¹² Another study from Israel detailed myocarditis following Pfizer’s COVID-19 jab in six male patients with a median age of 23 years.¹³

A similar study published in Pediatrics reported seven cases of acute myocarditis or myopericarditis in otherwise healthy adolescent males. Each had experienced chest pain within four days of receiving the second dose of Pfizer’s COVID-19 jab.¹⁴

Data published in JAMA Cardiology by physicians from the Navy, Army and Air Force also revealed a higher-than-expected rate of myocarditis in U.S. military personnel who received a COVID-19 jab.¹⁵

And a real-world case-control study from Israel¹⁶ revealed that the Pfizer COVID-19 jab is associated with a threefold increased risk of myocarditis,¹⁷ leading to the condition at a rate of 1 to 5 events per 100,000 persons.¹⁸ Other elevated risks were also identified following the COVID jab, including lymphadenopathy (swollen lymph nodes), appendicitis and herpes zoster infection.¹⁹

CDC, FDA Acknowledge Myocarditis Risk

The U.S. Centers for Disease Control and Prevention (CDC) acknowledges that COVID-19 shots are associated with an increased myocarditis risk, stating:²⁰

“In April 2021, increased cases of myocarditis and pericarditis were reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna). Data from multiple studies show a rare risk for myocarditis and/or pericarditis following receipt of mRNA COVID-19 vaccines.

These rare cases of myocarditis or pericarditis have occurred most frequently in adolescent and young adult males, ages 16 years and older, within 7 days after receiving the second dose of an mRNA COVID-19 vaccine (Pfizer-BioNTech and Moderna).”

The CDC is now investigating long-term effects of myocarditis after COVID-19 shots and is contacting people who have experienced chest pain, shortness of breath and feelings of having a fast-beating, fluttering or pounding heart following a COVID-19 shot. In order to meet the CDC’s case definition of myocarditis following a COVID-19 shot, you must also have “medical tests to support the diagnosis of myocarditis and rule out other causes.”²¹

However, despite the risk, the CDC is still advising children aged 12 and older to get the jab, and the U.S. Food and Drug Administration granted full approval August 23, 2021, to Pfizer’s COVID-19 mRNA injection, now sold under the brand name Comirnaty, for people aged 16 and older.²²

FDA does list myocarditis on the prescribing information for COVID-19 shots,²³ and in its approval letter for Comirnaty, the FDA ordered Pfizer to conduct research to investigate the risk of inflammation in and around the heart, as voluntary reporting mechanisms are insufficient.²⁴

The FDA accepted Pfizer’s suggested timetable for the post-approval study to evaluate incidence of heart and heart sack inflammation, which includes the submission of an interim report at the end of October 2023, a study completion date of June 30, 2025, and submission of a final report October 31, 2025.

British Health Agency Advises Against COVID-19 Jabs for Kids

Britain’s Joint Committee on Vaccination and Immunization (JCVI) recommended against COVID-9 injections for healthy 12- to 15-year-olds. JCVI member Adam Finn told Reuters:²⁵

“… the number of serious cases that we see of COVID in children this age are really very small. There are uncertainties about the long-term implications of (myocarditis), and that makes the risk-benefit balance for these children really quite tight and much tighter than we would be comfortable to make the recommendation."

In contrast, the CDC has downplayed the risks, stating that most people should still get jabbed: “The Advisory Committee on Immunization Practices (ACIP) and CDC have determined that the benefits (such as prevention of COVID-19 cases and its severe outcomes) outweigh the risks of myocarditis and pericarditis after receipt of mRNA COVID-19 vaccines.”²⁶

Others, however, aren’t so sure. Cardiologist Dr. Aseem Malhotra has spoken openly about the shots’ downfalls. He said in “Safe and Effective: A Second Opinion,” a documentary by Oracle Films:²⁷

“Having been double jabbed and being one of the first to take the Pfizer vaccine, I have — after several months critically appraising the data, speaking to eminent scientists in Oxford, Stanford and Harvard, speaking to two investigative medical journalists and being contacted by two Pfizer whistleblowers — reluctantly concluded that this vaccine is not completely safe and has unprecedented harms, which leads me to conclude that it needs to be suspended until all the raw data has been released for independent analysis.”

Deaths and Disabilities Ignored, Silenced

Myocarditis reduces your heart’s ability to pump and can cause rapid or abnormal heart rhythms that can be deadly. In severe cases, myocarditis can cause permanent damage to the heart muscle and lead to heart failure, heart attack, stroke and sudden cardiac death.²⁸ Tragic stories have accumulated worldwide:

· In August 2021, New Zealand reported the death of a woman following Pfizer’s COVID-19 jab, which they believe was due to vaccine-induced myocarditis.²⁹

· A previously healthy 36-year-old mother of two died 11 days after receiving a Pfizer COVID-19 shot; her death was deemed to be caused by myocarditis due to the shot.³⁰

· Dr. Neil Singh Dhalla, a CEO of a major health clinic, fell asleep four days after he got a COVID-19 booster shot — and died from a heart attack.³¹ The autopsy stated myocarditis. He was only 48 years old and had never had heart problems in his life.

· In another example, epidemiologists confirmed that two teenage boys from different U.S. states died of myocarditis days after getting the Pfizer shot.³² Both had received second doses of the shot. In a study that examined the autopsy findings, it’s reported that the “myocarditis” described in the boys’ deaths is “not typical myocarditis pathology.”³³

If you’re wondering why you haven’t heard more about these and other cases, it’s because Big Tech has tried to censor these stories and keep them from getting out. But the truth has a way of finding the light.

A U.S. judge ruled that the White House must release correspondence regarding a “massive censorship enterprise” with Big Tech; it’s alleged that federal agencies communicated with social media companies to suppress private speech during the pandemic.³⁴^,³⁵

Open debate and access to data from all sources is crucial to proper informed consent, including learning why some experts believe myocarditis due to COVID-19 shots “will kill kids,” without a doubt.³⁶

Sources and References

· ^1, ^4, ⁵ CMAJ November 21, 2022, 194 (45) E1529-E1536; DOI: 10.1503/cmaj.220676

· ^2, ²⁸ Mayo Clinic, Myocarditis

· ³ Rumble, Safe and Effective: A Second Opinion September 28, 2022, 37:18

· ⁶ University of Maryland, Center for Infectious Disease Research and Policy November 2022

· ^7, ⁸ EurekAlert November 21, 2022

· ⁹ CMAJ November 21, 2022, 194 (45) E1529-E1536; DOI: 10.1503/cmaj.220676, Conclusion

· ¹⁰ Journal of Cardiology Cases May 2022, Volume 25, Issue 5, Pages 285-288

· ¹¹ Journal of Medial Virology December 4, 2021

· ¹² Diabetes Metab Syndr. 2021 September-October; 15(5): 102205

· ¹³ Vaccine. 2021 Jun 29;39(29):3790-3793. DOI: 10.1016/j.vaccine.2021.05.087. Epub 2021 May 28

· ¹⁴ Pediatrics. 2021 Sep;148(3):e2021052478. DOI: 10.1542/peds.2021-052478. Epub 2021 Jun 4